66837-1-Ig
antibody from Proteintech Group
Targeting: MBNL1
EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL
Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66837-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- MBNL1 antibody
- Antibody type
- Monoclonal
- Description
- MBNL1 antibody (Cat. #66837-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat, pig and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat, Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1H2C12
- Vial size
- 20ul, 150ul
Submitted references Arc Capsids Facilitate the Transfer of Muscleblind.
Comparative Analysis of MBNL1 Antibodies: Characterization of Recognition Sites and Detection of RNA Foci Colocalization.
Systematic exploration of prognostic alternative splicing events related to tumor immune microenvironment of Clear Cell Renal Cell Carcinoma.
Hexahydrocurcumin suppresses hepatocellular carcinoma by regulating TRIM23/MBNL1 pathway.
Exosome-Delivered circSTAU2 Inhibits the Progression of Gastric Cancer by Targeting the miR-589/CAPZA1 Axis.
A comprehensive cuproptosis score and associated gene signatures reveal prognostic and immunological features of idiopathic pulmonary fibrosis.
MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation.
The MBNL1/circNTRK2/PAX5 pathway regulates aerobic glycolysis in glioblastoma cells by encoding a novel protein NTRK2-243aa.
Zinter M, Xiao C, M'Angale PG, Zhao-Shea R, Freels T, Tapper A, Thomson T
bioRxiv : the preprint server for biology 2026 Mar 10;
bioRxiv : the preprint server for biology 2026 Mar 10;
Comparative Analysis of MBNL1 Antibodies: Characterization of Recognition Sites and Detection of RNA Foci Colocalization.
Aoki Y, Ohki A, Yanaizu M, Kino Y
Genes 2025 May 29;16(6)
Genes 2025 May 29;16(6)
Systematic exploration of prognostic alternative splicing events related to tumor immune microenvironment of Clear Cell Renal Cell Carcinoma.
Wu H, Zhou Y, Wang X, Tang C, Yang F, Xu K, Ren T
Cancer biomarkers : section A of Disease markers 2025 Mar;42(3):18758592251317402
Cancer biomarkers : section A of Disease markers 2025 Mar;42(3):18758592251317402
Hexahydrocurcumin suppresses hepatocellular carcinoma by regulating TRIM23/MBNL1 pathway.
Wang M, Weng C, Xu J, Xu K
Scientific reports 2025 Jul 2;15(1):22541
Scientific reports 2025 Jul 2;15(1):22541
Exosome-Delivered circSTAU2 Inhibits the Progression of Gastric Cancer by Targeting the miR-589/CAPZA1 Axis.
Zhang C, Wei G, Zhu X, Chen X, Ma X, Hu P, Liu W, Yang W, Ruan T, Zhang W, Wu C, Tao K
International journal of nanomedicine 2023;18:127-142
International journal of nanomedicine 2023;18:127-142
A comprehensive cuproptosis score and associated gene signatures reveal prognostic and immunological features of idiopathic pulmonary fibrosis.
Jing C, Fu R, Liu X, Zang G, Zhu X, Wang C, Zhang W
Frontiers in immunology 2023;14:1268141
Frontiers in immunology 2023;14:1268141
MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation.
Jin B, Zhu J, Pan T, Yang Y, Liang L, Zhou Y, Zhang T, Teng Y, Wang Z, Wang X, Tian Q, Guo B, Li H, Chen T
Nucleic acids research 2023 Aug 25;51(15):7951-7971
Nucleic acids research 2023 Aug 25;51(15):7951-7971
The MBNL1/circNTRK2/PAX5 pathway regulates aerobic glycolysis in glioblastoma cells by encoding a novel protein NTRK2-243aa.
Zhao Y, Song J, Dong W, Liu X, Yang C, Wang D, Xue Y, Ruan X, Liu L, Wang P, Zhang M, Liu Y
Cell death & disease 2022 Sep 5;13(9):767
Cell death & disease 2022 Sep 5;13(9):767
No comments: Submit comment
No validations: Submit validation data